DISCO Pharmaceuticals

The surfaceome company

Cologne, Germany · Founded 2022 · $65.0M raised

Headquarters
Cologne
Employees
11–50
Founded
2022
Business Model
B2B
Total Funding
$65.0M
Last Round
$42.0M SeedDec 2025
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

DISCO Pharmaceuticals is a cancer drug discovery company headquartered in Cologne, Germany, with operations in Schlieren, Switzerland. Founded in May 2022 and spun out of ETH Zürich, DISCO has built a pioneering cell surfaceome mapping platform that expands the universe of druggable targets for oncology. The platform uses cell-surface proteomics combined with advanced protein community mapping to identify novel therapeutic targets on the surface of cancer cells — targets that are largely inaccessible to conventional drug discovery approaches. DISCO's initial discovery programs focus on Small Cell Lung Cancer and microsatellite-stable Colorectal Cancer. In January 2026, the company entered a license agreement with Amgen to advance novel cancer surfaceome-targeted therapies, shortly after completing a €36 million seed financing round.

Summary

DISCO Pharmaceuticals is a Biotech company based in Cologne, Germany, founded in 2022. It has raised $65.0M in total across 2 rounds, most recently a $42.0M Seed round in Dec 2025. Investors include Ackermans & van Haaren, NRW.BANK and Sofinnova Partners.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundDec 2025
$42.0M

Sign up to see all 2 events

Funding: Seed. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

DISCO Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/disco-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/disco-pharmaceuticals" alt="DISCO Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>